Cerus Corporation

Financials

総資産 221.41 M237.5 M218.09 M197.75 M200.92 M221.86 M 負債合計 117.61 M151.88 M149.53 M144.3 M144.02 M156.89 M 純資産合計 103.81 M85.62 M68.56 M53.44 M56.9 M64.97 M 負債および純資産合計 221.41 M237.5 M218.09 M197.75 M200.92 M221.86 M 有利子負債合計 48.1 M69.42 M69.8 M79.8 M84.16 M83.89 M 純負債 -66.7 M-41.77 M-14.92 M30.15 M17.64 M14.07 M

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

CERS

Financials

Cerus Corporation

ニュース

Cerus Corp最高法務責任者Jensen氏、18万7000ドル相当の株式を売却

Jensen, Cerus Corp chief legal officer, sells $187k in stock

Cerus Corp CFO、21万1000ドル相当の株式を売却

Cerus Corp CEO Greenmanが74万2000ドル相当の株式を売却

Cerus Corp COO、Jayaraman氏が27万3000ドル相当の株式を売却

Cerus Corp最高医療責任者Benjaminが16万8000ドル相当の株式を売却

Cerus Corp COO Jayaraman sells $273k in shares

Cerus Corp CEO Greenman sells $742k in shares

Cerus Corp: chief medical officer Benjamin sells $168k in shares

Cerus Corp CFO green sells $211k in shares

Cerus names COO Vivek Jayaraman as next CEO effective July 1

Cerus社CFOのKevin Green氏が16万9000ドル相当の株式を売却